4 top growth shares I’d buy today

The best time to buy any stock is when it’s trading at good value.

I think the following shares are all trading at attractive value and I’m close to pulling the trigger on one or more of these:

Greencross Limited (ASX: GXL)

The owner of Greencross vets, Petbarns and City Farmers is currently trading 24% lower than its 2017 high of $7.31.

There is a lot of negative sentiment surrounding the retail sector, plus Greencross experienced some bad news about one of its products.

I think Greencross could be a long-term winner due to the growth of the pet population and its clever strategy to co-locate a Greencross vet inside a Petbarn.

Greencross is currently trading at 12.5x FY18’s estimated earnings with a grossed-up dividend yield of 4.86%.

National Veterinary Care Ltd (ASX: NVL)

National Veterinary Care is a competitor to Greencross, it is a veterinary business that’s rapidly expanding in Australia and New Zealand.

Its share price is 15% lower than its 2017 high of $2.78. It appears to have been affected by the negativity surrounding Greencross, yet National Vet Care doesn’t have a retail segment, nor has it sold any potentially faulty products.

National Veterinary Care is currently trading at 24x FY17’s estimated earnings and is expected to start paying a dividend at its annual report.

Ramsay Health Care Limited (ASX: RHC)

Ramsay is one of the biggest private hospital operators in the world. There are significant ageing demographic tailwinds that should boost Ramsay for many decades to come.

The Ramsay share price is currently 18% lower than its all-time high in September 2016, I think this is a good price to buy this long-term growth stock.

Ramsay is currently trading at 26x FY17’s estimated earnings with a grossed-up dividend yield of 2.61%.

Healthscope Ltd (ASX: HSO)

Healthscope is the second biggest operator of private hospitals in Australia and has a large pipeline of growth projects to boost its number of hospital beds over the next few years.

Its shares are currently trading 15% lower than its 2017 high. I think this could be a good time for a long-term buy because Healthscope should benefit from the same ageing demographics as Ramsay.

Healthscope is currently trading at 19x FY17’s estimated earnings with an unfranked dividend yield of 3.57%.

Foolish takeaway

I think all four stocks are trading at attractive value and are worthy of being in any Foolish portfolio.

At the current prices I think National Veterinary Care and Healthscope are the best buys, but it’s always good to buy Ramsay at a bit of a discount too.

If you don't like the above four ideas then you're in luck because our analysts have prepared this report of even more growth stocks that should be great long-term buys.

Top 3 ASX Blue Chips To Buy In 2017

For many, blue chip stocks means stability, profitability and regular dividends, often fully franked..

But knowing which blue chips to buy, and when, can be fraught with danger.

The Motley Fool's in-house analyst team has poured over thousands of hours worth of proprietary research to bring you the names of "The Motley Fool's Top 3 Blue Chip Stocks for 2017."

Each one pays a fully franked dividend. Each one has not only grown its profits, but has also grown its dividend. One increased it by a whopping 33%, while another trades on a grossed up (fully franked) dividend yield of almost 7%.

If you're expecting to see the likes of Commonwealth Bank, Telstra and Wesfarmers shares on this list, you'll be sorely disappointed. Not only are their dividends growing at a snail's pace, their profits are under pressure too due to the increasing competitive environment.

The contrast to these "new breed" blue chips couldn't be greater... especially the very real prospect of significant share price gains, something that's looking less likely from the usual blue chip suspects.

The names of these Top 3 ASX Blue Chips are included in this specially prepared free report. But you will have to hurry. Depending on demand - and how quickly the share prices of these companies moves - we may be forced to remove this report.

Click here to claim your free report.

Motley Fool contributor Tristan Harrison owns shares of Greencross Limited, HEALTHSCPE DEF SET, NATVETCARE FPO, and Ramsay Health Care Limited. The Motley Fool Australia owns shares of Greencross Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

Two New Stock Picks Every Month!

Not to alarm you, but you’re about to miss a very important event! Chief Investment Advisor Scott Phillips and his team at Motley Fool Share Advisor are about to reveal their latest official stock recommendation. The premium “buy alert” will be unveiled to members and you can be among the first to act on the tip.

Don’t let this opportunity pass you by – this is your chance to get in early!

Simply enter your email now to find out how you can get instant access.

By clicking this button, you agree to our Terms of Service and Privacy Policy. We will use your email address only to keep you informed about updates to our website and about other products and services we think might interest you. You can unsubscribe from Take Stock at anytime. Please refer to our Financial Services Guide (FSG) for more information.